Genetic epidemiology of chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 3, 2010, Pages 283-291

  Estrella, Michelle M ^a   Sperati, Chistopher J ^a   Kao, Wen H L ^b   Parekh, Rulan S ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chronic kidney disease; Genetic; Genome wide association study; MYH9; UMOD

Indexed keywords

ACTIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYOSIN HEAVY CHAIN;

AFRICAN AMERICAN; ALBUMINURIA; CELL MEMBRANE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; ETHNIC GROUP; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GENOME; GENOMICS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; KIDNEY FUNCTION; MYH9 GENE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UMOD GENE;

HUMANS; KIDNEY DISEASES; MOLECULAR EPIDEMIOLOGY;

EID: 77951451300     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328338185f     Document Type: Review

References (42)

1. Fava C, Montagnana M, Burri P, et al. Determinants of kidney function in Swedish families: role of heritable factors. J Hypertens 2008; 26:1773-1779.
2. Fox CS, Yang Q, Cupples LA, et al. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. J Am Soc Nephrol 2004; 15:2457-2461.
3. Hunt SC, Coon H, Hasstedt SJ, et al. Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees. Am J Hypertens 2004; 17:511-515.
4. Parikh NI, Hwang SJ, Yang Q, et al. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 2008; 102:1194-1198.
5. Placha G, Poznik GD, Dunn J, et al. A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes 2006; 55:3358-3365.
6. Bochud M, Elston RC, Maillard M, et al. Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian ocean). Kidney Int 2005; 67:61-69. (Pubitemid 40019226)
7. Kottgen A, Glazer NL, Dehghan A, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41:712-717.
8. Rule AD, Larson TS, Bergstralh EJ, et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141:929-937.
9. Fogarty DG, Rich SS, Hanna L, et al. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 2000; 57:250-257. (Pubitemid 30227772)
10. Freedman BI, Beck SR, Rich SS, et al. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 2003; 42:291-296.
11. Rao F, Wessel J, Wen G, et al. Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension 2007; 49:1015-1031. (Pubitemid 351664306)
12. Levey AS, Cattran D, Friedman A, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the national kidney foundation and the US food and drug administration. Am J Kidney Dis 2009; 54:205-226.
13. Sedor JR, Schelling JR. Association of metabolic syndrome in nondiabetic patients with increased riskfor chronic kidney disease: the fat lady sings. J Am Soc Nephrol 2005; 16:1880-1882.
14. Zarif L, CovicA, Iyengar S, etal. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant 2000; 15:1801-1807.
15. Rogus JJ, Warram JH, Krolewski AS. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 2002; 51:1655-1662.
16. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens 2006; 15:276-284. (Pubitemid 43755803)
17. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24:2911-2935.
18. Placha G, Canani LH, Warram JH, Krolewski AS. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005; 12:155-169. (Pubitemid 40488998)
19. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008; 299:1335-1344.
20. Collins A. Allelic association: linkage disequilibrium structure and gene mapping. Mol Biotechnol 2009; 41:83-89.
21. Kao WH, Klag MJ, Meoni LA, etal. MYH9 is associated with nondiabetic endstage renal disease in African Americans. Nat Genet 2008; 40:1185-1192.
22. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40:1175-1184.
23. Zhu X, Tang H, Risch N. Admixture mapping and the role of population structure for localizing disease genes. Adv Genet 2008; 60:547-569.
24. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 2005; 366:1223-1234.
25. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4:45-61. (Pubitemid 44698579)
26. NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, et al. Replicating genotype-phenotype associations. Nature 2007; 447:655-660. (Pubitemid 46889722)
27. Little J, Higgins JP, IoannidisJP, etal. STrengthening the REporting of genetic association studies (STREGA): an extension of the STROBE statement. Ann Intern Med 2009; 150:206-215.
28. Arrondel C, Vodovar N, Knebelmann B, et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002; 13:65-74. (Pubitemid 34042012)
29. Freedman BI, Hicks PJ, Bostrom MA, etal. Nonmuscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 2009; 29: 626-632.
30. Freedman BI, Hicks PJ, Bostrom MA, etal. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 2009; 75:736-745.
31. Freedman BI, Kopp JB, Winkler CA, et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol 2009; 29:626-632.
32. Pattaro C, Aulchenko YS, Isaacs A, et al. Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int 2009; 76:297-306.
33. Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 2003; 42:658-676. (Pubitemid 37187366)
34. Kottgen A, Hwang SJ, Larson MG, et al. Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol 2010; 21:337-344.
35. Freedman BI, Bowden DW, Rich SS, etal. Genome-wide linkage scans for renal function and albuminuria in type 2 diabetes mellitus: the diabetes heart study. Diabet Med 2008; 25:268-276.
36. Ewens KG, George RA, Sharma K, et al. Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 2005; 54:3305-3318. (Pubitemid 43336530)
37. Schelling JR, Abboud HE, Nicholas SB, et al. Genome-wide scan for estimated glomerularfiltration rate in multiethnic diabetic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 2008; 57:235-243.
38. Rogus JJ, Poznik GD, Pezzolesi MG, et al. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach. Diabetes 2008; 57:2519-2526.
39. Muchmore AV, Decker JM. Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women. Science 1985; 229:479-481.
40. Devuyst O, Dahan K, Pirson Y. Tamm-Horsfall protein or uromodulin: new ideas about an old molecule. Nephrol Dial Transplant 2005; 20:1290-1294. (Pubitemid 41430599)
41. Goldstein DB. Common genetic variation and human traits. N Engl J Med 2009; 360:1696-1698.
42. Hirschhorn JN. Genomewide association studies illuminating biologic pathways. N Engl J Med 2009; 360:1699-1701.